oxcarbazepine has been researched along with eslicarbazepine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, PC; Benes, J; Cunha, RA; Figueiredo, AA; Freitas, AP; Garrett, J; Learmonth, DA; Parada, A; Soares-da-Silva, P | 1 |
| Czendlik, C; Flesch, G; Lloyd, P; Renard, D | 1 |
| Almeida, A; Alves, G; Falcão, A; Fortuna, A; Lopes, B; Soares-da-Silva, P | 1 |
| Bonifácio, MJ; Hebeisen, S; Loureiro, AI; Palma, N; Pires, N; Soares-da-Silva, P; Spanswick, D; Whyment, A | 1 |
| Kim, TH; Petrou, S; Reid, CA | 1 |
| Booker, SA; Cobb, S; Pires, N; Soares-da-Silva, P; Vida, I | 1 |
| Belarrinaga, B; Bermejo, PE; Dorado, R | 1 |
| Bermejo, PE; Dorado, R; Juarez, A | 1 |
| Crommen, J; Fillet, M; Janicot, B; Servais, AC; Takam, A | 1 |
| Bien, CG; Brandt, C; Hagemann, A; Klimpel, D; May, TW | 1 |
| Johnson-Davis, KL; Kroner, GM; Thomas, RL | 1 |
1 trial(s) available for oxcarbazepine and eslicarbazepine
| Article | Year |
|---|---|
Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
Topics: Administration, Oral; Adult; Anticonvulsants; Biological Availability; Carbamazepine; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Molecular Structure; Reproducibility of Results; Stereoisomerism; Tissue Distribution | 2011 |
10 other study(ies) available for oxcarbazepine and eslicarbazepine
| Article | Year |
|---|---|
Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.
Topics: Amides; Animals; Anticonvulsants; Azepines; Calcium Channel Blockers; Calcium Channels; Cerebral Cortex; Electroshock; In Vitro Techniques; Ion Channel Gating; Motor Activity; Prodrugs; Rats; Seizures; Sodium; Stereoisomerism; Structure-Activity Relationship; Synaptosomes | 1999 |
A chiral liquid chromatography method for the simultaneous determination of oxcarbazepine, eslicarbazepine, R-licarbazepine and other new chemical derivatives BIA 2-024, BIA 2-059 and BIA 2-265, in mouse plasma and brain.
Topics: Animals; Anticonvulsants; Brain; Calibration; Carbamazepine; Chromatography, Liquid; Dibenzazepines; Mice; Oxcarbazepine; Quality Control; Reference Standards; Spectrophotometry, Ultraviolet; Stereoisomerism | 2012 |
Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Cell Line, Tumor; Dibenzazepines; Dose-Response Relationship, Drug; Hippocampus; Lacosamide; Male; Mice; Organ Culture Techniques; Oxcarbazepine; Time Factors; Voltage-Gated Sodium Channels | 2015 |
Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy.
Topics: Animals; Anticonvulsants; Brain; Brain Waves; Carbamazepine; Dibenzazepines; Disease Models, Animal; Epilepsy, Generalized; Humans; Mice; Mice, Transgenic; Mutation; Oxcarbazepine; Receptors, GABA-A; Valproic Acid | 2015 |
Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors.
Topics: Action Potentials; Animals; Anticonvulsants; Behavior, Animal; CA1 Region, Hippocampal; Carbamazepine; CHO Cells; Cricetulus; Dibenzazepines; Excitatory Postsynaptic Potentials; In Vitro Techniques; Male; Mice; Motor Activity; Oxcarbazepine; Patch-Clamp Techniques; Protein Binding; Psychomotor Performance; Purinergic Agents; Pyramidal Cells; Receptor, Adenosine A1; Tritium | 2015 |
[Experience with eslicarbazepine in patients with hiponatremia due to carbamazepine and oxcarbacepine].
Topics: Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Substitution; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Therapeutic Equivalency | 2015 |
[Eslicarbazepine in patients with hipercholesterolemia associated to carbamazepine and oxcarbacepine].
Topics: Anticonvulsants; Carbamazepine; Dibenzazepines; Humans; Hypercholesterolemia | 2016 |
Liquid chromatography separation of the chiral prodrug eslicarbazepine acetate and its main metabolites in polar organic mode. Application to their analysis after in vitro metabolism.
Topics: Acetic Acid; Acetonitriles; Carbamazepine; Cellulose; Chromatography, Liquid; Dibenzazepines; Diethylamines; Humans; Microsomes, Liver; Oxcarbazepine; Phenylcarbamates; Prodrugs; Solid Phase Extraction; Solvents; Stereoisomerism | 2016 |
Influence of dose and antiepileptic comedication on brivaracetam serum concentrations in patients with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Dibenzazepines; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Oxcarbazepine; Phenobarbital; Phenytoin; Pyrrolidinones; Retrospective Studies; Young Adult | 2020 |
Retrospective Analysis of Pediatric and Adult Populations Using an LC-MS/MS Method for Oxcarbazepine/Eslicarbazepine Metabolite.
Topics: Adult; Child; Chromatography, Liquid; Dibenzazepines; Drug Monitoring; Humans; Oxcarbazepine; Retrospective Studies; Tandem Mass Spectrometry | 2021 |